Frank Takkinen
Stock Analyst at Lake Street
(1.19)
# 3,430
Out of 4,784 analysts
54
Total ratings
34.62%
Success rate
-13.36%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNSR LENSAR | Downgrades: Hold | $16 → $15 | $14.13 | +6.16% | 2 | Mar 24, 2025 | |
| HYPR Hyperfine | Initiates: Buy | $1.5 | $0.72 | +108.33% | 1 | Mar 24, 2025 | |
| AXGN Axogen | Initiates: Buy | $30 | $18.36 | +63.40% | 1 | Mar 17, 2025 | |
| SGHT Sight Sciences | Maintains: Hold | $3 → $2.5 | $2.55 | -1.96% | 3 | Mar 6, 2025 | |
| CLBT Cellebrite DI | Maintains: Buy | $17 → $26 | $19.46 | +33.61% | 3 | Feb 14, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $17 → $30 | $11.97 | +150.63% | 4 | Jan 21, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $4 → $5 | $2.59 | +93.05% | 2 | Jan 14, 2025 | |
| AVR Anteris Technologies Global | Initiates: Buy | $20 | $3.80 | +426.32% | 1 | Jan 8, 2025 | |
| NSPR InspireMD | Initiates: Buy | $5 | $2.70 | +85.19% | 1 | Dec 11, 2024 | |
| CVRX CVRx, Inc. | Maintains: Buy | $12 → $15 | $12.49 | +20.10% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2 → $4 | $2.15 | +86.05% | 6 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.24 | +547.77% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $24.25 | +23.71% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $2.64 | +278.79% | 2 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $6.82 | +75.95% | 1 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $1.36 | +341.18% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.80 | +122.22% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $11.85 | +1.27% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $305 → $350 | $157.24 | +122.59% | 1 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $5 | $2.14 | +133.64% | 3 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $1.30 | +592.31% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $2.15 | +644.19% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.75 | +1,130.67% | 2 | Jan 18, 2023 |
LENSAR
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $14.13
Upside: +6.16%
Hyperfine
Mar 24, 2025
Initiates: Buy
Price Target: $1.5
Current: $0.72
Upside: +108.33%
Axogen
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $18.36
Upside: +63.40%
Sight Sciences
Mar 6, 2025
Maintains: Hold
Price Target: $3 → $2.5
Current: $2.55
Upside: -1.96%
Cellebrite DI
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $19.46
Upside: +33.61%
ClearPoint Neuro
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $11.97
Upside: +150.63%
KORU Medical Systems
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $2.59
Upside: +93.05%
Anteris Technologies Global
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $3.80
Upside: +426.32%
InspireMD
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.70
Upside: +85.19%
CVRx, Inc.
Oct 30, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $12.49
Upside: +20.10%
Sep 30, 2024
Upgrades: Buy
Price Target: $2 → $4
Current: $2.15
Upside: +86.05%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $1.24
Upside: +547.77%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $24.25
Upside: +23.71%
Jun 21, 2024
Maintains: Buy
Price Target: $5 → $10
Current: $2.64
Upside: +278.79%
Jun 4, 2024
Initiates: Buy
Price Target: $12
Current: $6.82
Upside: +75.95%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $1.36
Upside: +341.18%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $1.80
Upside: +122.22%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $11.85
Upside: +1.27%
Aug 2, 2023
Maintains: Buy
Price Target: $305 → $350
Current: $157.24
Upside: +122.59%
Jul 19, 2023
Maintains: Buy
Price Target: $2.5 → $5
Current: $2.14
Upside: +133.64%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $1.30
Upside: +592.31%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $2.15
Upside: +644.19%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.75
Upside: +1,130.67%